Cryptobiotix

Technologiepark-Zwijnaarde 82

9052 Gent

BE

Cryptobiotix

Foundation date

27/01/2021

Sector

#Biotechnology - other

Subsector

Therapeutic areas

Preclinical CRO in the gastrointestinal space offering in vitro digestion and ex vivo gut microbiome research services. Cryptobiotix pushes the boundaries of preclinical gastrointestinal research with unparalleled throughput and biorelevance. From early R&D screening to in-depth characterisation of food products and therapeutics, we tailor your project to your research questions and provide you the data to accelerate and de-risk your product development.

Upcoming events

Latest news

  • argenx announces VYVGART (efgartigimod alfa) authorized for sale by Health Canada for generalized myasthenia gravis

    Thursday September 21st 2023

  • Galapagos appoints Simon Sturge to its Board of Directors

    Tuesday September 19th 2023

  • 13th Investment for HERAN Partners: Broken String Biosciences (UK)

    Tuesday September 19th 2023